High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM
NCT06045286
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Liver Metastases
Interventions
RADIATION:
Radiation: High- and Low-dose radiotherapy
DRUG:
PD-1 Inhibitors
Sponsor
Jiangsu Cancer Institute & Hospital